NRX Pharmaceuticals (B1Q.F) Q3 2024 Earnings

14AugConfirmed
Q2 2024
Q3 2024
-0.68
-0.63
-0.57
-0.51

Details

Expected EPS
-0.63106
Actual EPS
-0.6813632
Surprise EPS
-0.05
Surprise Percent
+7.97%

Description

NRX Pharmaceuticals (B1Q.F) has reported earnings of -0.6813632 per share for Q3 2024.

0 Comments

Share your thoughts